| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer | Chief Medical Officer | See Remarks
1 company
Grossi Federico is a Chief Medical Officer at Apellis Pharmaceuticals, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $3.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 375 | $45.43 | $17,036.25 | -0.4% | -17.5% | +12.5% | |
| Feb 1, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 375 | $40.58 | $15,217.50 | -0.4% | +9.7% | +34.3% | |
| Jan 14, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sale+OE | 375 | $40.56 | $15,210.00 | -0.5% | +30.8% | +30.2% | |
| Jan 3, 2022 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 375 | $47.31 | $17,741.25 | -0.5% | +19.6% | +3.1% | |
| Dec 15, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 375 | $42.88 | $16,080.00 | -0.5% | -9.7% | +18.2% | |
| Dec 1, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 375 | $42.40 | $15,900.00 | -0.6% | +2.9% | +14.6% | |
| Nov 15, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 625 | $43.50 | $27,187.50 | -1.0% | +6.9% | +10.8% | |
| Nov 1, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 625 | $30.70 | $19,187.50 | -1.0% | +23.9% | +86.6% | |
| Oct 14, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 750 | $34.57 | $25,927.50 | -1.1% | +17.7% | +60.8% | |
| Oct 1, 2021 | APLS Apellis Pharmaceuticals, Inc. | Chief Medical Officer | Sell | 750 | $33.26 | $24,945.00 | -1.1% | +42.8% | +103.3% |